• Assessing drug safety with QIAGEN Biomedical KB-AI

    Virtual - Americas - EST , United States

    Are you a healthcare professional, clinical researcher or data scientist interested in drug safety research? If so, you know how vital understanding a drug’s adverse effects is to maximize its […]

  • Assessing drug safety with QIAGEN Biomedical KB-AI

    HSMD-screen-grab-2

    Are you a healthcare professional, clinical researcher or data scientist interested in drug safety research? If so, you know how vital understanding a drug’s adverse effects is to maximize its […]

  • Checkpoint inhibitor and immuno-oncology investigation through OmicSoft Lands APIs

    HSMD-screen-grab-2

    While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data, such investigation is hindered by the difficulty in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high quality curated genomic repositories such as the QIAGEN OmicSoft Lands database immediately […]

  • Probing OncoLand using OmicSoft Studio

    Virtual - Americas - EST , United States

    There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI), you won't need a script to fetch the data you want. This training will show how high-quality curated genomic repositories, such as the QIAGEN OmicSoft Lands, immediately allow in-depth investigations across diverse oncology and normal tissues/cells data […]

  • Probing OncoLand using OmicSoft Studio

    HSMD-screen-grab-2

    There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI), you won't need a script to fetch the data you want. This training will show how high-quality curated genomic repositories, such as the QIAGEN OmicSoft Lands, immediately allow in-depth investigations across diverse oncology and normal tissues/cells data […]